Arlington, VA, United States of America

Christopher E Bradburne

This inventor holds 3 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2019-2023.


% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Arlington, VA (US) (2019 - 2020)
  • Ellicott City, MD (US) (2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Christopher E. Bradburne

Introduction

Christopher E. Bradburne is an accomplished inventor based in Arlington, VA. He has made significant contributions to the field of medical research, particularly in the area of viral infections. With a total of 3 patents to his name, his work focuses on innovative approaches to combat influenza and other viral diseases.

Latest Patents

One of his latest patents is titled "Influenza-activated constructs and methods of use thereof." This patent presents a novel approach for the treatment, prevention, and diagnosis of Cap-Snatching virus infections, particularly all classes of human influenza, including pandemic influenza. The methods involve the use of constructs for RNA-interference (RNAi), showcasing his commitment to advancing medical technology.

Career Highlights

Christopher is affiliated with Johns Hopkins University, where he continues to push the boundaries of research and innovation. His work has garnered attention for its potential impact on public health and disease management.

Collaborations

He has collaborated with notable colleagues, including Lucy M. Carruth and Matthew Yeager, further enhancing the scope and depth of his research endeavors.

Conclusion

Christopher E. Bradburne's innovative work in the field of viral infections exemplifies the importance of research and development in medicine. His contributions are paving the way for new treatments and preventive measures against influenza and other viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…